Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ Supernus Pharmaceuticals Inc. (SUPN) on Thursday reported net income of $7.9 million in its second quarter.
On a per-share basis, the Rockville, Maryland-based company said it had net income of 14 cents.
The drugmaker posted revenue of $170.1 million in the period.
Supernus expects full-year revenue in the range of $640 million to $680 million.
Insight by Contrast Security: During this exclusive webinar, moderator Jared Serbu and agency leaders discuss software implementation cyber risks and how they are measuring and mitigating those risks in their software ecosystem and supply chain. Register now!
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN
© 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.